Baxter Heparin Lawsuits

Heparin lawsuits enable individuals harmed by the widely used blood Heparin thinner to obtain compensation for their medical costs and other losses.

Heparin is a fast-acting blood thinning medication essential for some surgeries, blood clot treatments and dialysis. However, a heparin contamination brought to light in early 2008 has caused hundreds of serious health complications and at least 81 deaths.

Heparin Contamination
The heparin contamination occurred with vials of heparin produced by Baxter International, the American pharmaceutical manufacturer (with factories in China) responsible for generating around 50 percent of the heparin vials used in the United States.

To cut costs, Baxter's Chinese-based factory substituted the active ingredient heparin with a sulfate compound derived from shellfish. Although the sulfate substitute mimicked the effects of heparin, it reduced heparin concentrations between 2 and 60 percent per vial and started causing patients to develop serious health problems, such as violent allergic reactions.

Related Topics:

Baxter Heparin

Dangerous Drug Alert:

Baxter Recalls All Heparin Products

Other Heparin News:

Injured by Heparin Contamination?
Baxter eventually recalled all of its U.S.-sold heparin, but for some the company’s actions were too late. Those individuals who were harmed by contaminated heparin may be able to file a heparin lawsuit to recover damages such as:

Medical treatment costs
Pain and suffering
Lost income
More

Additionally, those who lost a family member because of the contamination may also be eligible to file a heparin lawsuit. Recoverable damages may include:

Loss of companionship
Loss of financial support
Mental anguish
Funeral/burial expenses

Learn More about Filing a Heparin Lawsuit
If you or a loved one has been exposed to contaminated heparin and has experienced health problems as a result, consult a personal injury attorney who specializes in heparin lawsuits. You may be entitled to financial compensation for your injuries and losses.

Baxter-heparin RSS Feed